NEW YORK (360Dx) – A point-of-care test that monitors the immune system's response without requiring manual processing could help clinicians treating sepsis, a condition that should be quickly detected to provide an optimal clinical effect, according to the test's developers at the University of Illinois and the Carle Foundation Hospital in Urbana, Illinois.

To monitor the immune system's response during infection or inflammation, the test looks for an increase in the expression of the CD64 protein marker on specific types of white blood cells called neutrophils.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.